• SENSEX 81,028.02
    1,718.01 (+2.17%)
  • BANKNIFTY 59,086.00
    1,312.35 (+2.27%)
  • Billionbrains
    208.75 112.02(%)
  • Lenskart Solut.
    733.10 767.40(%)
  • NSE
    1,953.95 1,953.95(%)
  • Cartrade Tech
    2,712.90 3,291.35(%)
  • Apar Inds.
    13,783.50 6,800.00(%)
  • Tonbo Imaging
    1,427.75 1,013.95(%)
  • M & M
    3,295.00 3,840.00(%)
  • Cummins India
    3,903.00 3,883.30(%)
  • HDFC Bank
    787.00 1,017.90(%)
  • ICICI Bank
    1,569.30 1,569.30(%)
  • Sai Life
    1,815.55 1,815.55(%)
  • Hitachi Energy
    26,720.00 16,104.00(%)
  • Avenue Super.
    3,408.40 3,104.00(%)
  • Axis Bank
    1,323.90 1,418.30(%)
  • Bharti Airtel
    2,120.00 2,174.70(%)
  • Larsen & Toubro
    4,118.90 4,440.00(%)
  • Jio Platforms
    1,390.00 1,356.40(%)
  • CG Power & Ind
    734.00 525.50(%)
  • Reliance Industries
    1,318.10 1,611.20(%)
  • SBI
    1,020.00 1,234.80(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Nectar Lifescience Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 23920.0
  • ISIN : INE023H01027
10.05 0 (-1.47%)
  • As on 07 Nov 2026 (EOD)

  • Today’s Low

    9.98

  • Today’s High

    10.25

  • Open

    10.25

  • Perv Close

    10.20

  • 52W Low

    9.30

  • 52W High

    22.40

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    195.23

  • Div & Yield %

    0.00

  • Book Value(₹)

    29.98

  • Debt-Equity Ratio

    -1.47

  • AGM Date

    06-Nov-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.65

  • Mar.Cap (₹Cr.)

    195.23

  • RONW (%)

    0.47

  • ROCE (%)

    5.96

Score Board

  • Equity (₹ in Cr.)

    19.43

  • BV (₹)

    30.00

  • Sales( ₹ in Cr.)

    0.00

  • NP (in Cr.)

    -240.63

  • NP Var(%)

    -112.0

  • Div%

    0.0

  • CPS (₹)

    -12.40

  • EPS (₹)

    -12.40

  • Traded Value (₹ in Lakhs)

    197.17

  • 52 Week High

    22.40

  • 52 Week Low

    9.30

  • Price BSE

    10.0

  • Price NSE

    10.00

  • Market Capital( in Cr.)

    197.17

  • P/C Ratio

    -0.80

  • P/E Ratio

    -0.80

  • Price Vs.BV

    -12.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 0.00 0.00 1,925.83 1,746.56 1,924.92 1,762.27
Excise Duty 0.00 0.00 241.75 222.89 256.69 220.45
Net Sales 0.00 0.00 1,684.08 1,523.67 1,668.23 1,541.82
Other Income 9.29 1.88 14.58 43.18 11.32 3.79
Stock Adjustments 0.00 0.00 40.21 41.64 -14.97 -102.80
Total Income 9.29 1.88 1,738.87 1,608.49 1,664.58 1,442.81
EXPENDITURE :            
Raw Materials 0.00 0.00 1,242.45 1,200.84 1,207.32 1,052.82
Power and Fuel Cost 0.10 0.05 129.52 127.39 101.41 84.63
Employee Cost 0.89 0.09 81.71 75.14 71.91 70.55
Other Manufacturing Expenses 0.01 0.00 55.30 44.88 45.09 44.16
Selling and Administration Expenses 4.39 0.05 61.38 61.01 66.82 72.00
Miscellaneous Expenses 290.85 114.38 2.37 1.32 1.90 31.04
Employee Benefit Expenses 0.89 0.09 81.71 75.14 71.91 70.55
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 296.24 114.57 1,572.73 1,510.59 1,494.44 1,355.19
Operating Profit -286.94 -112.69 166.13 97.91 170.13 87.63
Interest 36.13 0.00 87.14 79.48 78.81 112.03
Gross Profit -323.07 -112.69 78.99 18.43 91.32 -24.40
Depreciation 0.34 0.62 60.72 59.12 56.97 60.25
Profit Before Tax -323.41 -113.31 18.27 -40.69 34.35 -84.65
Current Tax -30.53 0.38 13.27 -18.24 9.03 -11.50
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit -292.89 -113.68 5.00 -22.46 25.32 -73.15
Extraordinary Items -52.25 0.04 0.18 40.51 9.41 -25.41
Adjusted Net Profit -240.64 -113.72 4.82 -62.97 15.91 -47.74
Adjustment below Net Profit 0.08 0.54 -0.34 0.19 0.81 0.00
P & L Balance brought forward 590.79 703.93 699.27 721.54 695.41 766.26
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 3.00 0.00 0.00 0.00 0.00 1.12
P & L Balance carried down 294.98 590.79 703.93 699.27 721.54 691.99
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -15.08 -5.07 0.22 -1.00 1.13 -3.26
Earnings Per Share(Adj)-Unit Curr -15.08 -5.07 0.22 -1.00 1.13 -3.26
Book Value 29.98 42.63 47.68 47.47 48.46 47.30
Book Value(Adj)-Unit Curr 29.98 42.63 47.68 47.47 48.46 47.30

Shareholding Pattern

  • Promoter Group

    51.84%

  • Public Share Holding

    48.16%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 100,706,448 51.84 100,706,448 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 100,706,448 51.84 100,706,448 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 44,020 0.02 44,020 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 972,635 0.50 972,635 9
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 7,577,547 3.90 7,577,547 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 8,594,202 4.42 8,594,202 11
2] Non Institution
Bodies Corporate 5,886,226 3.03 5,886,216 237
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,745,440 0.90 1,745,440 618
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 4,010,454 2.06 4,010,454 1,617
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 4,075,175 2.10 4,075,175 10
Individuals holding nominal share capital up to Rs. 1 lakh 69,002,945 35.52 69,002,835 69,835
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 65,000 0.03 65,000 1
Others 174,580 0.09 174,580 1
Sub Total 84,960,320 43.74 84,960,200 72,320
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 194,260,970 100.00 194,260,850 72,334

Company Background

Nectar Lifescience LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Nectar Lifescience Ltd
  • BSE Code : 23920.0
  • ISIN : INE023H01027

  • Incorporation Year

    1995

  • Registered Office

    Village Saidpura
    Tehsil Derabassi S A S Nagar, Mohali,
    Punjab-140507

  • Telephone

    91-1762-308000

  • FAX

    91-1762-308135

  • Chairman

    Sanjiv Goyal

  • Managing Director

    Sanjiv Goyal

  • Company Secretary

    Sanjaymohan Singh Rawat

  • Auditor

    Deepak Jindal & Co

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Nectar Lifescience Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Nectar Lifesci. 10.15 9.29 0.00 -0.81 0.05
Abbott India 26,340.05 7,217.19 6,929.05 34.66 43.78
Astrazeneca Phar 6,387.90 2,304.07 2,275.58 94.15 27.86
Glaxosmi. Pharma 2,524.85 3,932.76 3,790.20 37.52 58.17
Evonile Pharma 1,762.40 393.10 354.33 -1,087.90 15.94
Cipla 1,409.00 20,102.60 18,979.95 42.94 13.88
Bliss GVS Pharma 603.40 773.53 729.81 39.34 12.51
Amrutanjan Healt 513.30 520.13 502.55 25.90 24.16
Fermenta Biotec. 447.05 474.15 450.25 20.87 18.77
Guj. Themis Bio. 379.05 168.25 165.82 101.35 18.05
Ambalal Sarabhai 35.25 19.52 3.94 65.28 6.77